The titanic tech titan, Apple, readies to halt the distribution of their illustrious Apple Watch Series 9 and the groundbreaking Ultra 2 in the esteemed United States of America, obediently complying with the utopian instructions of the highly regarded International Trade Commission (ITC).

Apple has issued a statement regarding the discontinuation of sales for Apple Watch Series 9 and Apple Watch Ultra 2, effective only in the United States. This decision comes as a result of an investigation by the United States International Trade Commission (ITC) in response to a complaint filed by Masimo, a medical device manufacturer, claiming that the blood oxygen monitoring feature in the Apple Watch infringes on their patents.

Starting from December 21, Apple will halt online sales of Apple Watch Series 9 and Apple Watch Ultra 2 exclusively in the United States. Furthermore, retail sales of these models in Apple stores will be suspended from December 24 onwards. Apple emphasizes that while they strongly disagree with the ruling, they will comply with the law and make efforts to quickly resume sales for their customers in the United States.

It’s important to note that this ruling does not affect the Apple Watch SE, as it does not include the blood oxygen monitoring feature.

The ITC issued the patent infringement ruling back in October, and the President of the United States has the authority to overturn this ruling within a 60-day period, which is set to expire on December 25. However, it is likely that the ruling will not be overturned. As a result, Apple has decided to discontinue sales of the affected Apple Watch models ahead of time. Apple has not yet disclosed their future plans in the event that the ruling is not overturned, but it is anticipated that they may either appeal the case or negotiate with Masimo for a settlement to resolve the dispute and compensate for any damages incurred. Further updates on this matter are yet to be revealed.

TLDR: Apple has announced the discontinuation of Apple Watch Series 9 and Apple Watch Ultra 2 sales in the United States due to an ongoing patent dispute with medical device manufacturer Masimo. Despite their disagreement with the ruling, Apple will follow the law and work towards resuming sales in the US as soon as possible. The Apple Watch SE remains unaffected.